{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
An observational, cross-sectional survey to evaluate the management of patients with Allergic Rhinitis with nasal congestion and role of Fluticasone Oxymetazoline Fixed Dose Combination Nasal spray
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of allergic rhinitis do you see in a month? (Tick where applicable)*

  2. What is/are the predominant cardinal sign/s you observe in your patients with mild AR? *
    3. Signs Tick wherever applicable Percentage of patients with each predominant sign

    %

    %

    %

    %

    %
  3. What is/are the predominant cardinal sign/s you observe in your patients with moderate-severe AR? *
    4. Signs Tick wherever applicable Percentage of patients with each predominant sign

    %

    %

    %

    %

    %
  4. What much percentage of patients with AR (combined mild, moderate, severe) present with Nasal congestion in a month? (Tick where applicable)*

  5. What is the relative percentage of patients presenting as sneezers or blockers or both in your practice? *
    6. Signs Please provide percentages
    %
    %
    %
  6. What is the impact on sleep in patients having nasal congestion with AR? *

  7. What % of patients have nasal congestion in AR? *

  8. What is the impact on quality of life in patients having nasal congestion with AR? *

  9. How much percentage of patients with moderate to severe AR have their quality of life affected? *

  10. What is the impact on sleep in patients having nasal congestion with AR? *

  11. What percentage of your AR patients with nasal congestion suffer with concomitant asthma? (Tick where applicable)*

  12. What are the most common allergens you observe that triggers AR with nasal congestion? (Tick all applicable)*

  13. Which are the most common allergic comorbidities you observe in your patients with Nasal congestion as prominent feature of AR in your practice? *
  14. Which are the most common systemic comorbidities you observe in your patients with nasal congestion with AR? *
  15. Which are the most common investigations you perform in your practice for patients with nasal congestion with AR? *

  16. Which pharmacological management options you choose for your patients with mild AR with nasal congestion? *
    17. Drug class Molecule/s of choice Dosage Form Duration of treatment Follow up (Weeks/months)
  17. Please explain the pharmacological management for your patients with mild AR presenting with nasal congestion (eg. if one treatment is followed by other, frequency of follow ups and investigations done to assess the response) *
  18. Which pharmacological management options you choose for your patients with moderate- severe AR with nasal congestion? *
    19. Drug class Molecule/s of choice Dosage Form Duration of treatment Follow up (Weeks/months)
  19. Please explain the pharmacological management for your patients with moderate-severe AR presenting with nasal congestion (eg. if one treatment is followed by other, frequency of follow ups and investigations done to assess the response) *
  20. What percentage of patients with nasal congestion remain symptomatic with the standard prescribed dose of drugs used in pharmacotherapy? *

  21. How many patients do you routinely give oral, topical or both in your patients with AR with nasal congestion? *
    22. Dosage Form Molecule Duration of treatment Follow up (Weeks/months)
  22. What are the factors determining the choice of drug selection in patients with nasal congestion associated with AR? (Tick all applicable) *

  23. If both anti-histamines and LTRA are used, which is the choice of antihistaminic combination? *
    24. Drug class Dosage Form Duration of treatment Follow up (Weeks/months) Common Side effects
  24. What as per you are the clinical differences between fluticasone furoate and fluticasone propionate in relieving AR with Nasal Congestion? *
  25. Which molecule has faster onset of action in relieving AR with Nasal Congestion? *

  26. Which molecule has longer duration of action in relieving AR with Nasal Congestion? *

  27. Is oxymetazoline more effective than Xylometazoline in reducing nasal resistance and increasing airflow? *

  28. Do you observe tachyphylaxis with use of nasal decongestant like oxymetazoline? *

  29. For how long do you prefer to use oxymetazoline for your patients? *

  30. For how long do you prefer to use xylometazoline for your patients? *

  31. In your clinical practice, how many patients require a combination of INCS + decongestants (including patients of AR with nasal congestion)? *

  32. Amongst patients requiring INCS+ decongestants, how many patients are prescribed combination of fluticasone furoate plus oxymetazoline (including patients of AR with nasal congestion)? *

  33. What is the impact on quality of life in patients having nasal congestion with AR after taking fluticasone furoate plus oxymetazoline? *

  34. What is the impact on sleep in patients having nasal congestion with AR after taking fluticasone furoate plus oxymetazoline? *

  35. Based on your expertise, does addition of intranasal corticosteroid reduce the phenomenon of tachyphylaxis caused by oxymetazoline? *

  36. How as per your clinical experience will the FDC of fluticasone and oxymetazoline nasal spray act in a synergistic manner to relieve nasal congestion with AR? *
  37. Which is your preferred patient profile for fluticasone and oxymetazoline combination in AR? (eg. Based on age, symptoms, severity and comorbidities) *
  38. What according to you is the ideal treatment of nasal congestion in patients with AR? *
  39. Kindly specify the impact of nasal congestion in patients with AR? *
  40. For how long is FDC of fluticasone furoate and oxymetazoline given? *

  41. Do you feel the FDC of Fluticasone furoate and oxymetazoline nasal spray positively impacts patient outcome in terms of sleep quality? *
  42. Do you feel the FDC of Fluticasone furoate and oxymetazoline nasal spray positively impacts patient outcome in terms of quality of life? *
  43. Based on your clinical experience, in which other conditions does patient require fluticasone furoate+ Oxymetazoline? (apart from AR) *
  44. Probability of developing Rhinitis medicamentosa with Fluticasone furoate and oxymetazoline nasal spray is *

  45. How likely is recurrence of AR after treatment based on severity? *
    46. Mild AR Moderate- severe AR
  46. Apart from allergic rhinitis, is there any condition where oxymetazoline is useful? *
  47. Apart from allergic rhinitis, is there any condition where combination of oxymetazoline and fluticasone furoate is clinically useful? *